<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM PFIZER INC. AND SUBSIDIARY COMPANIES CONSOLIDATED BALANCE SHEET AND CONSOLIDATED STATEMENT OF INCOME FOR THE PERIOD ENDED DECEMBER 31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <CIK> 0000078003 <NAME> Pfizer <MULTIPLIER> 1,000,000 <PERIOD-TYPE> 12-MOS <FISCAL-YEAR-END> DEC-31-1998 <PERIOD-END> DEC-31-1998 <CASH> 1,552 <SECURITIES> 2,377 <RECEIVABLES> 2,981 <ALLOWANCES> (67) <INVENTORY> 1,828 <CURRENT-ASSETS> 9,931 <PP&E> 6,844 <DEPRECIATION> (2,429) <TOTAL-ASSETS> 18,302 <CURRENT-LIABILITIES> 7,192 <BONDS> 527 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 70 <OTHER-SE> 17,085 <TOTAL-LIABILITY-AND-EQUITY> 18,302 <SALES> 12,677 <TOTAL-REVENUES> 13,544 <CGS> 2,094 <TOTAL-COSTS> 2,094 <OTHER-EXPENSES> 2,279 <LOSS-PROVISION> 40 <INTEREST-EXPENSE> 136 <INCOME-PRETAX> 2,594 <INCOME-TAX> 642 <INCOME-CONTINUING> 1,950 <DISCONTINUED> 1,401 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 3,351 <EPS-PRIMARY> 2.65<F1> <EPS-DILUTED> 2.55 <FN> <F1> The information reported above under "EPS-PRIMARY" represents basic earnings per share for the year ended December 31, 1998. </FN>